These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10166407)

  • 21. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
    Lipton RB; Schmidt P; Diener HC
    Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
    Dodick DW; Turkel CC; DeGryse RE; Diener HC; Lipton RB; Aurora SK; Nolan ME; Silberstein SD
    J Pain; 2015 Feb; 16(2):164-75. PubMed ID: 25464159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in migraine.
    Mannix LK; Solomon GD
    Clin Neurosci; 1998; 5(1):38-42. PubMed ID: 9523057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacotherapy of headache with special reference to migraine].
    Beubler E
    Wien Med Wochenschr; 1994; 144(5-6):100-1. PubMed ID: 8053212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
    Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
    Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily sumatriptan for detoxification from rebound.
    Drucker P; Tepper S
    Headache; 1998 Oct; 38(9):687-90. PubMed ID: 15613182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
    Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
    Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal study.
    Dahlöf CG
    Cephalalgia; 1995 Oct; 15(5):414-22; discussion 336. PubMed ID: 8536303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in primary headache disorders: A review.
    Abu Bakar N; Tanprawate S; Lambru G; Torkamani M; Jahanshahi M; Matharu M
    Cephalalgia; 2016 Jan; 36(1):67-91. PubMed ID: 25888584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of headache in Europe: a review for the Eurolight project.
    Stovner LJ; Andrée C;
    J Headache Pain; 2008 Jun; 9(3):139-46. PubMed ID: 18418547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morbidity and medication preferences of individuals with headache presenting to a community pharmacy.
    Wenzel RG; Schommer JC; Marks TG
    Headache; 2004 Jan; 44(1):90-4. PubMed ID: 14979890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in migraine and chronic daily headache patients.
    Monzón MJ; Láinez MJ
    Cephalalgia; 1998 Nov; 18(9):638-43. PubMed ID: 9876889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting disability and quality of life in a community-based sample of women with migraine headache.
    Kolotylo CJ; Broome ME
    Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.
    Hansen EK; Olesen J
    Cephalalgia; 2017 Jan; 37(1):11-19. PubMed ID: 26924839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing health-related quality of life in patients with migraine.
    Becker WJ
    Can J Neurol Sci; 2002 Jun; 29 Suppl 2():S16-22. PubMed ID: 12139081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of headaches and medication use in patients with recurrent vertigo].
    López-Escámez JA; López-Nevot A
    Acta Otorrinolaringol Esp; 2000; 51(5):377-82. PubMed ID: 11000677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.